| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.305 | 3.517 | 4.346 | 2.125 | 1.713 | 1.783 | 202 | 303 | - | - |
| Total Income - EUR | 5.305 | 3.517 | 4.346 | 2.125 | 1.713 | 1.783 | 202 | 303 | - | - |
| Total Expenses - EUR | 3.919 | 4.725 | 4.451 | 1.908 | 1.906 | 1.451 | 495 | 283 | - | - |
| Gross Profit/Loss - EUR | 1.386 | -1.207 | -105 | 217 | -193 | 332 | -293 | 20 | - | - |
| Net Profit/Loss - EUR | 1.227 | -1.313 | -235 | 153 | -244 | 275 | -299 | 11 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Endograd Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 512 | 193 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Current Assets | 1.970 | 959 | 781 | 934 | 157 | 443 | 126 | 135 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 867 | 48 | 47 | 874 | 45 | 44 | 43 | 0 | - | - |
| Cash | 1.103 | 911 | 734 | 60 | 111 | 398 | 83 | 135 | - | - |
| Shareholders Funds | 1.835 | 504 | 260 | 409 | 157 | 429 | 120 | 132 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 647 | 648 | 521 | 526 | 0 | 14 | 6 | 3 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endograd Srl